Tomlinson B - Search Results

1

In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?

Tomlinson B, Hu M, Lee VW. Tomlinson B, et al. Mol Nutr Food Res. 2008 Jul;52(7):799-809. doi: 10.1002/mnfr.200700454. Mol Nutr Food Res. 2008. PMID: 18618477 Review.

2

Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole.

Yin OQ, Tomlinson B, Waye MM, Chow AH, Chow MS. Yin OQ, et al. Among authors: tomlinson b. Pharmacogenetics. 2004 Dec;14(12):841-50. doi: 10.1097/00008571-200412000-00007. Pharmacogenetics. 2004. PMID: 15608563

3

Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.

Tam LS, Li EK, Leung VY, Griffith JF, Benzie IF, Lim PL, Whitney B, Lee VW, Lee KK, Thomas GN, Tomlinson B. Tam LS, et al. Among authors: tomlinson b. J Rheumatol. 2005 Feb;32(2):275-82. J Rheumatol. 2005. PMID: 15693087 Clinical Trial.

4

Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study.

Lee KK, Lee VW, Chan WK, Lee BS, Chong AC, Wong JC, Yin D, Alemao E, Tomlinson B. Lee KK, et al. Among authors: tomlinson b. Value Health. 2008 Mar;11 Suppl 1:S91-8. doi: 10.1111/j.1524-4733.2008.00372.x. Value Health. 2008. PMID: 18387073 Free article.

5

Febuxostat in the management of hyperuricemia and chronic gout: a review.

Hu M, Tomlinson B. Hu M, et al. Among authors: tomlinson b. Ther Clin Risk Manag. 2008 Dec;4(6):1209-20. doi: 10.2147/tcrm.s3310. Ther Clin Risk Manag. 2008. PMID: 19337428 Free PMC article.

6

Clinical outcome of hypertension management.

Lee VW, Chan TH, Ko TT, Lee KK, Tomlinson B. Lee VW, et al. Among authors: tomlinson b. J Med Econ. 2008;11(1):101-18. doi: 10.3111/13696990801913950. J Med Econ. 2008. PMID: 19450113 Free article.

7

Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Liu ZK, et al. Among authors: tomlinson b. Atherosclerosis. 2010 Feb;208(2):427-32. doi: 10.1016/j.atherosclerosis.2009.08.013. Epub 2009 Aug 15. Atherosclerosis. 2010. PMID: 19732897

8

Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong.

Lee VW, Chau TS, Leung VP, Lee KK, Tomlinson B. Lee VW, et al. Among authors: tomlinson b. Chin Med J (Engl). 2009 Dec 5;122(23):2814-9. Chin Med J (Engl). 2009. PMID: 20092783

9

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.

Tomlinson B, Hu M, Lee VW, Lui SS, Chu TT, Poon EW, Ko GT, Baum L, Tam LS, Li EK. Tomlinson B, et al. Clin Pharmacol Ther. 2010 May;87(5):558-62. doi: 10.1038/clpt.2009.232. Epub 2010 Feb 3. Clin Pharmacol Ther. 2010. PMID: 20130569 Clinical Trial.

10

Effects of concomitant therapy with diltiazem on the lipid responses to simvastatin in Chinese subjects.

You JH, Chan WK, Chung PF, Hu M, Tomlinson B. You JH, et al. Among authors: tomlinson b. J Clin Pharmacol. 2010 Oct;50(10):1151-8. doi: 10.1177/0091270009358082. Epub 2010 Feb 11. J Clin Pharmacol. 2010. PMID: 20150526 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters